Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-002012
Filing Date
2024-11-18
Accepted
2024-11-18 06:46:05
Documents
51
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q clrb-20240930x10q.htm   iXBRL 10-Q 1360635
2 EX-31.1 clrb-20240930xex31d1.htm EX-31.1 10952
3 EX-31.2 clrb-20240930xex31d2.htm EX-31.2 10950
4 EX-32.1 clrb-20240930xex32d1.htm EX-32.1 9537
  Complete submission text file 0001410578-24-002012.txt   5583699

Data Files

Seq Description Document Type Size
5 EX-101.SCH clrb-20240930.xsd EX-101.SCH 35078
6 EX-101.CAL clrb-20240930_cal.xml EX-101.CAL 30919
7 EX-101.DEF clrb-20240930_def.xml EX-101.DEF 182532
8 EX-101.LAB clrb-20240930_lab.xml EX-101.LAB 285619
9 EX-101.PRE clrb-20240930_pre.xml EX-101.PRE 266217
54 EXTRACTED XBRL INSTANCE DOCUMENT clrb-20240930x10q_htm.xml XML 839526
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36598 | Film No.: 241469728
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)